These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
(Mark One) | |||||
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
||||||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
|
|
|
|
☑ | Accelerated Filer | ☐ | ||||||||
Non-accelerated Filer | ☐ | Smaller Reporting Company |
|
||||||||
(Do not check if a smaller reporting company) | Emerging growth company |
|
PART I – FINANCIAL INFORMATION | Page No. | |||||||
PART II – OTHER INFORMATION | ||||||||
Sep. 30, 2023 | Jul. 1, 2023 | ||||||||||||||||
(unaudited) | |||||||||||||||||
ASSETS | |||||||||||||||||
Current assets | |||||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||||||||
Accounts receivable, less allowances of $
|
|
|
|||||||||||||||
Inventories |
|
|
|||||||||||||||
Prepaid expenses and other current assets |
|
|
|||||||||||||||
Income tax receivable |
|
|
|||||||||||||||
Total current assets |
|
|
|||||||||||||||
Plant and equipment at cost, less accumulated depreciation |
|
|
|||||||||||||||
Other long-term assets | |||||||||||||||||
Goodwill |
|
|
|||||||||||||||
Intangibles, less amortization |
|
|
|||||||||||||||
Deferred income taxes |
|
|
|||||||||||||||
Operating lease right-of-use assets, net |
|
|
|||||||||||||||
Other assets |
|
|
|||||||||||||||
Total other long-term assets |
|
|
|||||||||||||||
Total assets | $ |
|
$ |
|
|||||||||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||||||||||||
Current liabilities | |||||||||||||||||
Accounts payable | $ |
|
$ |
|
|||||||||||||
Accrued expenses |
|
|
|||||||||||||||
Accrued income taxes |
|
|
|||||||||||||||
Current operating lease liabilities |
|
|
|||||||||||||||
Current maturities of long-term debt |
|
|
|||||||||||||||
Total current liabilities |
|
|
|||||||||||||||
Long-term liabilities | |||||||||||||||||
Long-term debt |
|
|
|||||||||||||||
Deferred income taxes |
|
|
|||||||||||||||
Long-term operating lease liabilities |
|
|
|||||||||||||||
Other long-term liabilities |
|
|
|||||||||||||||
Total long-term liabilities |
|
|
|||||||||||||||
Noncontrolling interest |
|
|
|||||||||||||||
Shareholders’ equity | |||||||||||||||||
Preferred stock, par value $
|
|
|
|||||||||||||||
Common stock, par value $
|
|
|
|||||||||||||||
Paid-in capital |
|
|
|||||||||||||||
Retained earnings |
|
|
|||||||||||||||
Accumulated other comprehensive loss |
(
|
(
|
|||||||||||||||
Treasury stock at cost,
|
(
|
(
|
|||||||||||||||
Total shareholders’ equity |
|
|
|||||||||||||||
Total liabilities and shareholders’ equity | $ |
|
$ |
|
13-Week Period Ended | |||||||||||||||||||||||
Sep. 30, 2023 | Oct. 1, 2022 | ||||||||||||||||||||||
Sales | $ |
|
$ |
|
|||||||||||||||||||
Cost of sales |
|
|
|||||||||||||||||||||
Gross profit |
|
|
|||||||||||||||||||||
Operating expenses |
|
|
|||||||||||||||||||||
Operating income |
|
|
|||||||||||||||||||||
Interest expense |
|
|
|||||||||||||||||||||
Other expense (income), net
(1)
|
|
|
|||||||||||||||||||||
Earnings before income taxes |
|
|
|||||||||||||||||||||
Income taxes |
|
|
|||||||||||||||||||||
Net earnings | $ |
|
$ |
|
|||||||||||||||||||
Net earnings: | |||||||||||||||||||||||
Basic earnings per share | $ |
|
$ |
|
|||||||||||||||||||
Diluted earnings per share |
|
|
|||||||||||||||||||||
Average shares outstanding |
|
|
|||||||||||||||||||||
Diluted shares outstanding |
|
|
(1)
|
|
13-Week Period Ended | |||||||||||||||||||||||||||||
Sep. 30, 2023 | Oct. 1, 2022 | ||||||||||||||||||||||||||||
Net earnings | $ |
|
$ |
|
|||||||||||||||||||||||||
Other comprehensive income (loss): | |||||||||||||||||||||||||||||
Foreign currency translation adjustment |
(
|
(
|
|||||||||||||||||||||||||||
Items presented net of tax: | |||||||||||||||||||||||||||||
Amortization of cash flow hedges |
|
|
|||||||||||||||||||||||||||
Change in net investment hedges |
|
|
|||||||||||||||||||||||||||
Change in cash flow hedges |
|
(
|
|||||||||||||||||||||||||||
Changes in excluded components of fair value hedge |
(
|
|
|||||||||||||||||||||||||||
Amortization of prior service cost |
|
|
|||||||||||||||||||||||||||
Amortization of actuarial loss |
|
|
|||||||||||||||||||||||||||
Net actuarial gain arising in current year |
|
|
|||||||||||||||||||||||||||
Change in marketable securities |
(
|
(
|
|||||||||||||||||||||||||||
Total other comprehensive loss |
(
|
(
|
|||||||||||||||||||||||||||
Comprehensive income | $ |
|
$ |
|
Accumulated
Other Comprehensive Loss |
|||||||||||||||||||||||||||||||||||||||||||||||
Common Stock |
Paid-in
Capital |
Retained
Earnings |
Treasury Stock | ||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amounts | Totals | |||||||||||||||||||||||||||||||||||||||||||
Balance as of July 1, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||
Net earnings |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Amortization of cash flow hedges, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in cash flow hedges, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Changes in excluded components of fair value hedge, net of tax |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Reclassification of pension and other postretirement benefit plans amounts to net earnings, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Net actuarial gain arising in current year, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in marketable securities, net of tax |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Treasury stock purchases |
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation awards |
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
Balance as of September 30, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||
Accumulated
Other Comprehensive Loss |
|||||||||||||||||||||||||||||||||||||||||||||||
Common Stock |
Paid-in
Capital |
Retained
Earnings |
Treasury Stock | ||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amounts | Totals | |||||||||||||||||||||||||||||||||||||||||||
Balance as of July 2, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||
Net earnings |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Amortization of cash flow hedges, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in cash flow hedges, net of tax |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in net investment hedges, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Reclassification of pension and other postretirement benefit plans amounts to net earnings, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in marketable securities, net of tax |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Treasury stock purchases |
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation awards |
(
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
Balance as of October 1, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
13-Week Period Ended | |||||||||||
Sep. 30, 2023 | Oct. 1, 2022 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net earnings | $ |
|
$ |
|
|||||||
Adjustments to reconcile net earnings to cash provided by operating activities: | |||||||||||
Share-based compensation expense |
|
|
|||||||||
Depreciation and amortization |
|
|
|||||||||
Operating lease asset amortization |
|
|
|||||||||
Amortization of debt issuance and other debt-related costs |
|
|
|||||||||
Deferred income taxes |
(
|
(
|
|||||||||
Provision for losses on receivables |
|
|
|||||||||
Other non-cash items |
(
|
|
|||||||||
Additional changes in certain assets and liabilities, net of effect of businesses acquired: | |||||||||||
Increase in receivables |
(
|
(
|
|||||||||
Increase in inventories |
(
|
(
|
|||||||||
Increase in prepaid expenses and other current assets |
(
|
(
|
|||||||||
(Decrease) increase in accounts payable |
(
|
|
|||||||||
Decrease in accrued expenses |
(
|
(
|
|||||||||
Decrease in operating lease liabilities |
(
|
(
|
|||||||||
Increase in accrued income taxes |
|
|
|||||||||
Decrease in other assets |
|
|
|||||||||
Decrease in other long-term liabilities |
(
|
(
|
|||||||||
Net cash provided by operating activities |
|
|
|||||||||
Cash flows from investing activities: | |||||||||||
Additions to plant and equipment |
(
|
(
|
|||||||||
Proceeds from sales of plant and equipment |
|
|
|||||||||
Acquisition of businesses, net of cash acquired |
(
|
(
|
|||||||||
Purchase of marketable securities |
(
|
(
|
|||||||||
Proceeds from sales of marketable securities |
|
|
|||||||||
Other investing activities |
|
|
|||||||||
Net cash used for investing activities |
(
|
(
|
|||||||||
Cash flows from financing activities: | |||||||||||
Bank and commercial paper borrowings, net |
|
|
|||||||||
Other debt borrowings including senior notes |
|
|
|||||||||
Other debt repayments including senior notes |
(
|
(
|
|||||||||
Debt issuance costs |
(
|
|
|||||||||
Proceeds from stock option exercises |
|
|
|||||||||
Stock repurchases |
(
|
(
|
|||||||||
Dividends paid |
(
|
(
|
|||||||||
Other financing activities |
(
|
(
|
|||||||||
Net cash provided by (used for) financing activities |
|
(
|
|||||||||
Effect of exchange rates on cash, cash equivalents and restricted cash |
(
|
(
|
|||||||||
Net decrease in cash, cash equivalents and restricted cash |
(
|
(
|
|||||||||
Cash, cash equivalents and restricted cash at beginning of period |
|
|
|||||||||
Cash, cash equivalents and restricted cash at end of period | $ |
|
$ |
|
|||||||
Supplemental disclosures of cash flow information: | |||||||||||
Cash paid during the period for: | |||||||||||
Interest | $ |
|
$ |
|
|||||||
Income taxes, net of refunds |
|
|
|||||||||
Sep. 30, 2023 | Oct. 1, 2022 | ||||||||||
(In thousands) | |||||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||
Restricted cash
(1)
|
|
|
|||||||||
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows | $ |
|
$ |
|
(1)
|
Restricted cash primarily represents cash and cash equivalents of Sysco’s wholly owned captive insurance subsidiary, restricted for use to secure the insurer’s obligations for workers’ compensation, general liability and auto liability programs. Restricted cash is located within other assets in each consolidated balance sheet.
|
Sep. 30, 2023 | Oct. 1, 2022 | ||||||||||
(In thousands) | |||||||||||
Non-cash investing and financing activities: | |||||||||||
Plant and equipment acquired through financing programs | $ |
|
$ |
|
|||||||
Assets obtained in exchange for finance lease obligations |
|
|
Sep. 30, 2023 | Jul. 1, 2023 | Oct. 1, 2022 | Jul. 2, 2022 | ||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Financed payment obligations | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
13-Week Period Ended Sep. 30, 2023 | ||||||||||||||||||||||||||||||||
US Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Principal Product Categories | ||||||||||||||||||||||||||||||||
Canned and dry products | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
Fresh and frozen meats |
|
|
|
|
|
|||||||||||||||||||||||||||
Frozen fruits, vegetables, bakery and other |
|
|
|
|
|
|||||||||||||||||||||||||||
Dairy products |
|
|
|
|
|
|||||||||||||||||||||||||||
Poultry |
|
|
|
|
|
|||||||||||||||||||||||||||
Fresh produce |
|
|
|
|
|
|||||||||||||||||||||||||||
Paper and disposables |
|
|
|
|
|
|||||||||||||||||||||||||||
Seafood |
|
|
|
|
|
|||||||||||||||||||||||||||
Beverage products |
|
|
|
|
|
|||||||||||||||||||||||||||
Other
(1)
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total Sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
(1)
|
Other sales relate to non-food products, including textiles and amenities for our hotel supply business, equipment, and other janitorial products, medical supplies and smallwares.
|
13-Week Period Ended Oct. 1, 2022 | ||||||||||||||||||||||||||||||||
US Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Principal Product Categories | ||||||||||||||||||||||||||||||||
Canned and dry products | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
Fresh and frozen meats |
|
|
|
|
|
|||||||||||||||||||||||||||
Frozen fruits, vegetables, bakery and other |
|
|
|
|
|
|||||||||||||||||||||||||||
Poultry |
|
|
|
|
|
|||||||||||||||||||||||||||
Dairy products |
|
|
|
|
|
|||||||||||||||||||||||||||
Fresh produce |
|
|
|
|
|
|||||||||||||||||||||||||||
Paper and disposables |
|
|
|
|
|
|||||||||||||||||||||||||||
Seafood |
|
|
|
|
|
|||||||||||||||||||||||||||
Beverage products |
|
|
|
|
|
|||||||||||||||||||||||||||
Other
(1)
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total Sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
(1)
|
Other sales relate to non-food products, including textiles and amenities for our hotel supply business, equipment, and other janitorial products, medical supplies and smallwares.
|
Assets Measured at Fair Value as of Sep. 30, 2023 | |||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash equivalents | |||||||||||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Other assets
(1)
|
|
|
|
|
|||||||||||||||||||
Total assets at fair value | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
(1)
|
Represents restricted cash balance recorded within other assets in the consolidated balance sheet. |
Assets Measured at Fair Value as of Jul. 1, 2023 | |||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash equivalents | |||||||||||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Other assets
(1)
|
|
|
|
|
|||||||||||||||||||
Total assets at fair value | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
(1)
|
Represents restricted cash balance recorded within other assets in the consolidated balance sheet. |
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||
Amortized Cost Basis | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Short-Term Marketable Securities | Long-Term Marketable Securities | ||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Fixed income securities: | |||||||||||||||||||||||||||||||||||
Corporate bonds | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Government bonds |
|
|
(
|
|
|
|
|||||||||||||||||||||||||||||
Total marketable securities | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Jul. 1, 2023 | |||||||||||||||||||||||||||||||||||
Amortized Cost Basis | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Short-Term Marketable Securities | Long-Term Marketable Securities | ||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Fixed income securities: | |||||||||||||||||||||||||||||||||||
Corporate bonds | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Government bonds |
|
|
(
|
|
|
|
|||||||||||||||||||||||||||||
Total marketable securities | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
Sep. 30, 2023 | |||||
(In thousands) | |||||
Due in one year or less | $ |
|
|||
Due after one year through five years |
|
||||
Due after five years through ten years |
|
||||
Total | $ |
|
Maturity Date of the Hedging Instrument | Currency / Unit of Measure | Notional Value | ||||||||||||
(In millions) | ||||||||||||||
Hedging of foreign currency risk | ||||||||||||||
Various (October 2023) | Swedish Krona |
|
||||||||||||
Various (October 2023 to April 2024) | British Pound Sterling |
|
||||||||||||
May 2024 | Mexican Peso |
|
||||||||||||
April 2025 | Canadian Dollar |
|
||||||||||||
Hedging of fuel risk | ||||||||||||||
Various (October 2023 to December 2025) | Gallons |
|
Derivative Fair Value | |||||||||||||||||
Balance Sheet location | Sep. 30, 2023 | Jul. 1, 2023 | |||||||||||||||
(In thousands) | |||||||||||||||||
Fair Value Hedges: | |||||||||||||||||
Cross currency swaps | Other current liabilities | $ |
|
$ |
|
||||||||||||
Cross currency swaps | Other long-term liabilities |
|
|
||||||||||||||
Cash Flow Hedges: | |||||||||||||||||
Fuel swaps | Other current assets |
|
|
||||||||||||||
Foreign currency forwards | Other current assets |
|
|
||||||||||||||
Fuel swaps | Other assets |
|
|
||||||||||||||
Fuel swaps | Other current liabilities |
|
|
||||||||||||||
Foreign currency forwards | Other current liabilities |
|
|
||||||||||||||
Fuel swaps | Other long-term liabilities |
|
|
||||||||||||||
13-Week Period Ended | ||||||||||||||||||||||||||
Sep. 30, 2023 | Oct. 1, 2022 | |||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||
Total amounts of income and expense line items presented in the consolidated results of operations in which the effects of fair value hedges are recorded | $ |
|
$ |
|
||||||||||||||||||||||
Gain or (loss) on fair value hedging relationships: | ||||||||||||||||||||||||||
Interest rate swaps: | ||||||||||||||||||||||||||
Hedged items | $ |
|
$ |
|
||||||||||||||||||||||
Derivatives designated as hedging instruments |
|
(
|
||||||||||||||||||||||||
Cross currency swaps: | ||||||||||||||||||||||||||
Hedged items | $ |
|
$ |
|
||||||||||||||||||||||
Derivatives designated as hedging instruments |
(
|
|
||||||||||||||||||||||||
13-Week Period Ended | ||||||||||||||||||||||||||
Sep. 30, 2023 | Oct. 1, 2022 | |||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||
Interest expense | $ |
|
$ |
(
|
||||||||||||||||||||||
Decrease in fair value of debt |
|
(
|
||||||||||||||||||||||||
Foreign currency gain (loss) |
(
|
|
||||||||||||||||||||||||
Hedged items | $ |
|
$ |
|
13-Week Period Ended Sep. 30, 2023 | |||||||||||||||||
Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivatives | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | |||||||||||||||
(In thousands) | (In thousands) | ||||||||||||||||
Derivatives in cash flow hedging relationships: | |||||||||||||||||
Fuel swaps | $ |
|
Operating expense | $ |
|
||||||||||||
Foreign currency contracts |
(
|
Cost of sales / Other income |
|
||||||||||||||
Total | $ |
|
$ |
|
|||||||||||||
Derivatives in net investment hedging relationships: | |||||||||||||||||
Foreign denominated debt | $ |
|
N/A | $ |
|
||||||||||||
Derivatives in fair value hedging relationships: | |||||||||||||||||
Change in excluded component of fair value hedge | $ |
(
|
Other expense (income) | $ |
|
||||||||||||
13-Week Period Ended Oct. 1, 2022 | |||||||||||||||||
Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivatives | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | |||||||||||||||
(In thousands) | (In thousands) | ||||||||||||||||
Derivatives in cash flow hedging relationships: | |||||||||||||||||
Fuel swaps | $ |
(
|
Operating expense | $ |
|
||||||||||||
Foreign currency contracts |
|
Cost of sales / Other income |
|
||||||||||||||
Total | $ |
(
|
$ |
|
|||||||||||||
Derivatives in net investment hedging relationships: | |||||||||||||||||
Foreign denominated debt | $ |
|
N/A | $ |
|
||||||||||||
13-Week Period Ended | |||||||||||||||||||||||
Sep. 30, 2023 | Oct. 1, 2022 | ||||||||||||||||||||||
(In thousands, except for share
and per share data) |
|||||||||||||||||||||||
Numerator: | |||||||||||||||||||||||
Net earnings | $ |
|
$ |
|
|||||||||||||||||||
Denominator: | |||||||||||||||||||||||
Weighted-average basic shares outstanding |
|
|
|||||||||||||||||||||
Dilutive effect of share-based awards |
|
|
|||||||||||||||||||||
Weighted-average diluted shares outstanding |
|
|
|||||||||||||||||||||
Basic earnings per share | $ |
|
$ |
|
|||||||||||||||||||
Diluted earnings per share | $ |
|
$ |
|
13-Week Period Ended Sep. 30, 2023 | |||||||||||||||||||||||
Location of
Expense (Income) Recognized in Net Earnings |
Before Tax
Amount |
Tax |
Net of Tax
Amount |
||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Pension and other postretirement benefit plans: | |||||||||||||||||||||||
Other comprehensive income before
reclassification adjustments: |
|||||||||||||||||||||||
Net actuarial gain, arising in the current year | Other expense, net | $ |
|
$ |
|
$ |
|
||||||||||||||||
Total other comprehensive income before reclassification adjustments |
|
|
|
||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of prior service cost | Other expense, net |
|
|
|
|||||||||||||||||||
Amortization of actuarial loss, net | Other expense, net |
|
|
|
|||||||||||||||||||
Total reclassification adjustments |
|
|
|
||||||||||||||||||||
Foreign currency translation: | |||||||||||||||||||||||
Foreign currency translation adjustment | N/A |
(
|
|
(
|
|||||||||||||||||||
Marketable securities: | |||||||||||||||||||||||
Change in marketable securities
(1)
|
N/A |
(
|
(
|
(
|
|||||||||||||||||||
Hedging instruments: | |||||||||||||||||||||||
Other comprehensive income (loss) before reclassification adjustments: | |||||||||||||||||||||||
Change in excluded component of fair value
hedge |
Other expense, net |
(
|
(
|
(
|
|||||||||||||||||||
Change in cash flow hedges |
Operating expenses
(2)
|
|
|
|
|||||||||||||||||||
Total other comprehensive income (loss) before reclassification adjustments |
|
|
|
||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of cash flow hedges | Interest expense |
|
|
|
|||||||||||||||||||
Total other comprehensive income (loss) | $ |
(
|
$ |
|
$ |
(
|
(1)
|
Realized gains or losses on marketa
ble securities are presented within other (income) expense, net in the consolidated results of operations; however, there were no significant gains or losses realized in the first
quarter
of fiscal 2024.
|
||||
(2)
|
Amount partially impacts operating expense for fuel swaps accounted for as cash flow hedges.
|
13-Week Period Ended Oct. 1, 2022 | |||||||||||||||||||||||
Location of
Expense (Income) Recognized in Net Earnings |
Before Tax
Amount |
Tax |
Net of Tax
Amount |
||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Pension and other postretirement benefit plans: | |||||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of prior service cost | Other expense, net | $ |
|
$ |
|
$ |
|
||||||||||||||||
Amortization of actuarial loss, net | Other expense, net |
|
|
|
|||||||||||||||||||
Total reclassification adjustments |
|
|
|
||||||||||||||||||||
Foreign currency translation: | |||||||||||||||||||||||
Foreign currency translation adjustment | N/A |
(
|
|
(
|
|||||||||||||||||||
Marketable securities: | |||||||||||||||||||||||
Change in marketable securities
(1)
|
N/A |
(
|
(
|
(
|
|||||||||||||||||||
Hedging instruments: | |||||||||||||||||||||||
Other comprehensive income (loss) before reclassification adjustments: | |||||||||||||||||||||||
Change in cash flow hedges |
Operating expenses
(2)
|
(
|
(
|
(
|
|||||||||||||||||||
Change in net investment hedges | N/A |
|
|
|
|||||||||||||||||||
Total other comprehensive income before reclassification adjustments |
(
|
(
|
(
|
||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of cash flow hedges | Interest expense |
|
|
|
|||||||||||||||||||
Total other comprehensive income (loss) | $ |
(
|
$ |
|
$ |
(
|
(1)
|
Realized gains or losses on marketable securities are presented within other (income) expense, net in the consolidated results of operations; however, there were
no
significant gains or losses realized in the
first
quarter of fiscal
2023
.
|
||||
(2)
|
Amount partially impacts operating expense for fuel swaps accounted for as cash flow hedges.
|
13-Week Period Ended Sep. 30, 2023 | |||||||||||||||||||||||||||||
Pension and Other Postretirement Benefit Plans,
net of tax |
Foreign Currency Translation |
Hedging,
net of tax |
Marketable Securities,
net of tax |
Total | |||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||
Balance as of Jul. 1, 2023 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||
Net actuarial loss arising in the current year |
|
— | — | — |
|
||||||||||||||||||||||||
Equity adjustment from foreign currency translation | — |
(
|
— | — |
(
|
||||||||||||||||||||||||
Amortization of cash flow hedges | — | — |
|
— |
|
||||||||||||||||||||||||
Change in excluded component of fair value hedge | — | — |
(
|
— |
(
|
||||||||||||||||||||||||
Change in cash flow hedge | — | — |
|
— |
|
||||||||||||||||||||||||
Amortization of unrecognized prior service cost |
|
— | — | — |
|
||||||||||||||||||||||||
Amortization of unrecognized net actuarial losses |
|
— | — | — |
|
||||||||||||||||||||||||
Change in marketable securities | — | — | — |
(
|
(
|
||||||||||||||||||||||||
Balance as of Sep. 30, 2023 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
13-Week Period Ended Oct. 1, 2022 | |||||||||||||||||||||||||||||
Pension and Other Postretirement Benefit Plans,
net of tax |
Foreign Currency Translation |
Hedging,
net of tax |
Marketable Securities | Total | |||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||
Balance as of Jul. 2, 2022 | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||||||
Equity adjustment from foreign currency translation | — |
(
|
— | — |
(
|
||||||||||||||||||||||||
Amortization of cash flow hedges | — | — |
|
— |
|
||||||||||||||||||||||||
Change in net investment hedges | — | — |
|
— |
|
||||||||||||||||||||||||
Change in cash flow hedge | — | — |
(
|
— |
(
|
||||||||||||||||||||||||
Amortization of unrecognized prior service cost |
|
— | — | — |
|
||||||||||||||||||||||||
Amortization of unrecognized net actuarial losses |
|
— | — | — |
|
||||||||||||||||||||||||
Change in marketable securities | — | — | — |
(
|
(
|
||||||||||||||||||||||||
Balance as of Oct. 1, 2022 | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
13-Week Period Ended | |||||||||||||||||||||||
Sep. 30, 2023 | Oct. 1, 2022 | ||||||||||||||||||||||
Sales: | (In thousands) | ||||||||||||||||||||||
U.S. Foodservice Operations | $ |
|
$ |
|
|||||||||||||||||||
International Foodservice Operations |
|
|
|||||||||||||||||||||
SYGMA |
|
|
|||||||||||||||||||||
Other |
|
|
|||||||||||||||||||||
Total | $ |
|
$ |
|
|||||||||||||||||||
13-Week Period Ended | |||||||||||||||||||||||
Sep. 30, 2023 | Oct. 1, 2022 | ||||||||||||||||||||||
Operating income (loss): | (In thousands) | ||||||||||||||||||||||
U.S. Foodservice Operations | $ |
|
$ |
|
|||||||||||||||||||
International Foodservice Operations |
|
|
|||||||||||||||||||||
SYGMA |
|
|
|||||||||||||||||||||
Other |
|
|
|||||||||||||||||||||
Total segments |
|
|
|||||||||||||||||||||
Global Support Center |
(
|
(
|
|||||||||||||||||||||
Total operating income |
|
|
|||||||||||||||||||||
Interest expense |
|
|
|||||||||||||||||||||
Other expense, net |
|
|
|||||||||||||||||||||
Earnings before income taxes | $ |
|
$ |
|
13-Week Period Ended | |||||||||||||||||||||||
Sep. 30, 2023 | Oct. 1, 2022 | ||||||||||||||||||||||
Sales | 100.0 | % | 100.0 | % | |||||||||||||||||||
Cost of sales | 81.4 | 81.8 | |||||||||||||||||||||
Gross profit | 18.6 | 18.2 | |||||||||||||||||||||
Operating expenses | 14.5 | 14.4 | |||||||||||||||||||||
Operating income | 4.1 | 3.8 | |||||||||||||||||||||
Interest expense | 0.7 | 0.6 | |||||||||||||||||||||
Other expense (income), net | — | 0.1 | |||||||||||||||||||||
Earnings before income taxes | 3.4 | 3.1 | |||||||||||||||||||||
Income taxes | 0.8 | 0.7 | |||||||||||||||||||||
Net earnings | 2.6 | % | 2.4 | % |
13-Week Period Ended | |||||||||||
Sep. 30, 2023 | |||||||||||
Sales | 2.6 | % | |||||||||
Cost of sales | 2.1 | ||||||||||
Gross profit | 4.6 | ||||||||||
Operating expenses | 3.3 | ||||||||||
Operating income | 9.1 | ||||||||||
Interest expense | 8.2 | ||||||||||
Other expense (income), net
(1)
|
(62.6) | ||||||||||
Earnings before income taxes | 11.4 | ||||||||||
Income taxes | 23.1 | ||||||||||
Net earnings | 8.1 | % | |||||||||
Basic earnings per share | 8.7 | % | |||||||||
Diluted earnings per share | 8.8 | ||||||||||
Average shares outstanding | (0.5) | ||||||||||
Diluted shares outstanding | (0.6) |
(1)
|
Other expense (income), net was expense of $6.6 million and $17.7 million in the first quarter of fiscal 2024 and fiscal 2023, respectively.
|
||||
13-Week Period Ended Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Global Support Center |
Consolidated
Totals |
||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Sales | $ | 13,723,799 | $ | 3,683,210 | $ | 1,906,014 | $ | 307,431 | $ | — | $ | 19,620,454 | |||||||||||||||||||||||
Sales increase (decrease) | 0.9 | % | 12.2 | % | (1.4) | % | 0.1 | % | 2.6 | % | |||||||||||||||||||||||||
Percentage of total | 69.9 | % | 18.8 | % | 9.7 | % | 1.6 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income (loss) | $ | 940,971 | $ | 93,483 | $ | 12,767 | $ | 11,823 | $ | (255,462) | $ | 803,582 | |||||||||||||||||||||||
Operating income (loss) increase (decrease) | 3.9 | % | 7.5 | % | NM | 2.5 | % | (6.5) | % | 9.1 | % | ||||||||||||||||||||||||
Percentage of total segments | 88.9 | % | 8.8 | % | 1.2 | % | 1.1 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income as a percentage of sales | 6.9 | % | 2.5 | % | 0.7 | % | 3.8 | % | 4.1 | % |
13-Week Period Ended Oct. 1, 2022 | |||||||||||||||||||||||||||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Global Support Center |
Consolidated
Totals |
||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Sales | $ | 13,602,482 | $ | 3,283,735 | $ | 1,933,457 | $ | 307,156 | $ | — | $ | 19,126,830 | |||||||||||||||||||||||
Percentage of total | 71.1 | % | 17.2 | % | 10.1 | % | 1.6 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income (loss) | $ | 905,712 | $ | 86,980 | $ | 5,696 | $ | 11,538 | $ | (273,125) | $ | 736,801 | |||||||||||||||||||||||
Percentage of total segments | 89.7 | % | 8.6 | % | 0.6 | % | 1.1 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income as a percentage of sales | 6.7 | % | 2.6 | % | 0.3 | % | 3.8 | % | 3.9 | % |
13-Week Period Ended Sep. 30, 2023 | 13-Week Period Ended Oct. 1, 2022 | Change in Dollars | % Change | ||||||||||||||||||||
(Dollars in thousands) | |||||||||||||||||||||||
Sales | $ | 13,723,799 | $ | 13,602,482 | $ | 121,317 | 0.9 | % | |||||||||||||||
Gross profit | 2,684,775 | 2,612,343 | 72,432 | 2.8 | |||||||||||||||||||
Operating expenses | 1,743,804 | 1,706,631 | 37,173 | 2.2 | |||||||||||||||||||
Operating income | $ | 940,971 | $ | 905,712 | $ | 35,259 | 3.9 | % | |||||||||||||||
Gross profit | $ | 2,684,775 | $ | 2,612,343 | $ | 72,432 | 2.8 | % | |||||||||||||||
Adjusted operating expenses (Non-GAAP) | 1,731,201 | 1,696,686 | 34,515 | 2.0 | |||||||||||||||||||
Adjusted operating income (Non-GAAP) | $ | 953,574 | $ | 915,657 | $ | 37,917 | 4.1 | % | |||||||||||||||
Increase (Decrease) | |||||||||||||||||||||||
13-Week Period | |||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||
Cause of change | Percentage | Dollars | |||||||||||||||||||||
Case volume
(1)
|
1.6 | % | $ | 206.5 | |||||||||||||||||||
Deflation | (0.4) | (49.1) | |||||||||||||||||||||
Other
(2)
|
(0.3) | (36.1) | |||||||||||||||||||||
Total change in sales | 0.9 | % | $ | 121.3 | |||||||||||||||||||
(1) |
Case volumes increased 1.6% compared to the first quarter of fiscal 2023. This volume increase resulted in a 1.6% increase in the dollar value of sales compared to the first quarter of fiscal 2023.
|
||||
(2)
|
Case volume reflects our broadline and specialty businesses, with the exception of our specialty meats business, which measures its volume in pounds. Any impact in volumes from these specialty meats operations is included within “Other.”
|
13-Week Period Ended Sep. 30, 2023 | 13-Week Period Ended Oct. 1, 2022 | Change in Dollars | % Change | ||||||||||||||||||||
(Dollars in thousands) | |||||||||||||||||||||||
Sales | $ | 3,683,210 | $ | 3,283,735 | $ | 399,475 | 12.2 | % | |||||||||||||||
Gross profit | 732,039 | 649,265 | 82,774 | 12.7 | |||||||||||||||||||
Operating expenses | 638,556 | 562,285 | 76,271 | 13.6 | |||||||||||||||||||
Operating income | $ | 93,483 | $ | 86,980 | $ | 6,503 | 7.5 | % | |||||||||||||||
Gross profit | $ | 732,039 | $ | 649,265 | $ | 82,774 | 12.7 | % | |||||||||||||||
Adjusted operating expenses (Non-GAAP) | 615,856 | 542,364 | 73,492 | 13.6 | |||||||||||||||||||
Adjusted operating income (Non-GAAP) | $ | 116,183 | $ | 106,901 | $ | 9,282 | 8.7 | % | |||||||||||||||
Sales on a constant currency basis (Non-GAAP) | $ | 3,577,707 | $ | 3,283,735 | $ | 293,972 | 9.0 | % | |||||||||||||||
Gross profit on a constant currency basis (Non-GAAP) | 705,328 | 649,265 | 56,063 | 8.6 | |||||||||||||||||||
Adjusted operating expenses on a constant currency basis (Non-GAAP) | 590,439 | 542,364 | 48,075 | 8.9 | |||||||||||||||||||
Adjusted operating income on a constant currency basis (Non-GAAP) | $ | 114,889 | $ | 106,901 | $ | 7,988 | 7.5 | % | |||||||||||||||
Increase (Decrease) | |||||||||||||||||||||||
13-Week Period | |||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||
Cause of change | Percentage | Dollars | |||||||||||||||||||||
Inflation | 7.6 | % | $ | 248.8 | |||||||||||||||||||
Foreign currency | 3.2 | 105.5 | |||||||||||||||||||||
Other
(1)
|
1.4 | 45.2 | |||||||||||||||||||||
Total change in sales | 12.2 | % | $ | 399.5 | |||||||||||||||||||
(1)
|
The impact of volumes as a component of sales growth from international operations are included within “Other.” Volume in our foreign operations includes volume metrics that differ from country to country and cannot be aggregated on a consistent, comparable basis.
|
The discussion of our results includes certain non-GAAP financial measures, including EBITDA and adjusted EBITDA, that we believe provide important perspective with respect to underlying business trends. Other than EBITDA and free cash flow, any non-GAAP financial measures will be denoted as adjusted measures to remove (1) restructuring charges; (2) expenses associated with our various transformation initiatives; (3) severance charges; and (4) acquisition-related costs consisting of: (a) intangible amortization expense and (b) acquisition costs and due diligence costs related to our acquisitions. Our results for fiscal 2023 were also impacted by adjustments to a product return allowance pertaining to COVID-related personal protection equipment inventory and the reduction of bad debt expense previously recognized in fiscal 2020 due to the impact of the COVID-19 pandemic on the collectability of our pre-pandemic trade receivable balances.
|
||
The results of our operations can be impacted due to changes in exchange rates applicable in converting local currencies to U.S. dollars. We measure our results on a constant currency basis. Constant currency operating results are calculated by translating current-period local currency operating results with the currency exchange rates used to translate the financial statements in the comparable prior-year period to determine what the current-period U.S. dollar operating results would have been if the currency exchange rate had not changed from the comparable prior-year period. | ||
Management believes that adjusting its operating expenses, operating income, net earnings and diluted earnings per share to remove these Certain Items and presenting its results on a constant currency basis provides an important perspective with respect to our underlying business trends and results. It provides meaningful supplemental information to both management and investors that (1) is indicative of the performance of the company’s underlying operations and (2) facilitates comparisons on a year-over-year basis. | ||
Sysco has a history of growth through acquisitions and excludes from its non-GAAP financial measures the impact of acquisition-related intangible amortization, acquisition costs and due-diligence costs for those acquisitions. We believe this approach significantly enhances the comparability of Sysco’s results for fiscal year 2024 and fiscal year 2023. | ||
Set forth on the following page is a reconciliation of sales, operating expenses, operating income, other (income) expense, net earnings and diluted earnings per share to adjusted results for these measures for the periods presented. Individual components of diluted earnings per share may not be equal to the total presented when added due to rounding. Adjusted diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding. |
13-Week Period Ended Sep. 30, 2023 | 13-Week Period Ended Oct. 1, 2022 | Change in Dollars | %/bps Change | ||||||||||||||||||||
Sales (GAAP) | $ | 19,620,454 | $ | 19,126,830 | $ | 493,624 | 2.6 | % | |||||||||||||||
Impact of currency fluctuations
(1)
|
(104,066) | — | (104,066) | (0.6) | |||||||||||||||||||
Comparable sales using a constant currency basis (Non-GAAP) | $ | 19,516,388 | $ | 19,126,830 | $ | 389,558 | 2.0 | % | |||||||||||||||
Cost of sales (GAAP) | $ | 15,972,682 | $ | 15,637,975 | $ | 334,707 | 2.1 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
— | 2,571 | (2,571) | NM | |||||||||||||||||||
Cost of sales adjusted for Certain Items (Non-GAAP) | $ | 15,972,682 | $ | 15,640,546 | $ | 332,136 | 2.1 | % | |||||||||||||||
Gross profit (GAAP) | $ | 3,647,772 | $ | 3,488,855 | $ | 158,917 | 4.6 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
— | (2,571) | 2,571 | NM | |||||||||||||||||||
Gross profit adjusted for Certain Items (Non-GAAP) | 3,647,772 | 3,486,284 | 161,488 | 4.6 | |||||||||||||||||||
Impact of currency fluctuations
(1)
|
(26,184) | — | (26,184) | (0.7) | |||||||||||||||||||
Comparable gross profit adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 3,621,588 | $ | 3,486,284 | $ | 135,304 | 3.9 | % | |||||||||||||||
Gross margin (GAAP) | 18.59 | % | 18.24 | % | 35 bps | ||||||||||||||||||
Impact of inventory valuation adjustment
(2)
|
— | (0.01) | 1 bps | ||||||||||||||||||||
Gross margin adjusted for Certain Items (Non-GAAP) | 18.59 | 18.23 | 36 bps | ||||||||||||||||||||
Impact of currency fluctuations
(1)
|
(0.03) | — | -3 bps | ||||||||||||||||||||
Comparable gross margin adjusted for Certain Items using a constant currency basis (Non-GAAP) | 18.56 | % | 18.23 | % | 33 bps | ||||||||||||||||||
Operating expenses (GAAP) | $ | 2,844,190 | $ | 2,752,054 | $ | 92,136 | 3.3 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
(19,675) | (11,645) | (8,030) | (69.0) | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
(31,038) | (29,454) | (1,584) | (5.4) | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
— | 2,592 | (2,592) | NM | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | 2,793,477 | 2,713,547 | 79,930 | 2.9 | |||||||||||||||||||
Impact of currency fluctuations
(1)
|
(25,838) | — | (25,838) | (0.9) | |||||||||||||||||||
Comparable operating expenses adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 2,767,639 | $ | 2,713,547 | $ | 54,092 | 2.0 | % | |||||||||||||||
Operating expense as a percentage of sales (GAAP) | 14.50 | % | 14.39 | % | 11 bps | ||||||||||||||||||
Impact of certain item adjustments | (0.26) | (0.20) | -6 bps | ||||||||||||||||||||
Adjusted operating expense as a percentage of sales (Non-GAAP) | 14.24 | % | 14.19 | % | 5 bps | ||||||||||||||||||
Operating income (GAAP) | $ | 803,582 | $ | 736,801 | $ | 66,781 | 9.1 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
— | (2,571) | 2,571 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
19,675 | 11,645 | 8,030 | 69.0 | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
31,038 | 29,454 | 1,584 | 5.4 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
— | (2,592) | 2,592 | NM | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | 854,295 | 772,737 | 81,558 | 10.6 | |||||||||||||||||||
Impact of currency fluctuations
(1)
|
(346) | — | (346) | (0.1) | |||||||||||||||||||
Comparable operating income adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 853,949 | $ | 772,737 | $ | 81,212 | 10.5 | % | |||||||||||||||
Operating margin (GAAP) | 4.10 | % | 3.85 | % | 25 bps | ||||||||||||||||||
Operating margin adjusted for Certain Items (Non-GAAP) | 4.35 | % | 4.04 | % | 31 bps |
13-Week Period Ended Sep. 30, 2023 | 13-Week Period Ended Oct. 1, 2022 | Change in Dollars | %/bps Change | ||||||||||||||||||||
Operating margin adjusted for Certain Items using a constant currency basis (Non-GAAP) | 4.38 | % | 4.04 | % | 34 bps | ||||||||||||||||||
Net earnings (GAAP) | $ | 503,392 | $ | 465,568 | $ | 37,824 | 8.1 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
— | (2,571) | 2,571 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
19,675 | 11,645 | 8,030 | 69.0 | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
31,038 | 29,454 | 1,584 | 5.4 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
— | (2,592) | 2,592 | NM | |||||||||||||||||||
Tax impact of inventory valuation adjustment
(6)
|
— | 637 | (637) | NM | |||||||||||||||||||
Tax impact of restructuring and transformational project costs
(6)
|
(4,847) | (2,884) | (1,963) | (68.1) | |||||||||||||||||||
Tax impact of acquisition-related costs
(6)
|
(7,646) | (7,295) | (351) | (4.8) | |||||||||||||||||||
Tax impact of bad debt reserves adjustments
(6)
|
— | 642 | (642) | NM | |||||||||||||||||||
Net earnings adjusted for Certain Items (Non-GAAP) | $ | 541,612 | $ | 492,604 | $ | 49,008 | 9.9 | % | |||||||||||||||
Diluted earnings per share (GAAP) | $ | 0.99 | $ | 0.91 | $ | 0.08 | 8.8 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
— | (0.01) | 0.01 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
0.04 | 0.02 | 0.02 | 100.0 | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
0.06 | 0.06 | — | — | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
— | (0.01) | 0.01 | NM | |||||||||||||||||||
Tax impact of restructuring and transformational project costs
(6)
|
(0.01) | (0.01) | — | — | |||||||||||||||||||
Tax impact of acquisition-related costs
(6)
|
(0.02) | (0.01) | (0.01) | (100.0) | |||||||||||||||||||
Diluted earnings per share adjusted for Certain Items (Non-GAAP)
(7)
|
$ | 1.07 | $ | 0.97 | $ | 0.10 | 10.3 | % | |||||||||||||||
(1)
|
Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on the current year results.
|
||||
(2)
|
Fiscal 2023 represents an adjustment to a product return allowance, related to COVID-related personal protection equipment inventory. | ||||
(3)
|
Fiscal 2024 includes $6 million related to restructuring and severance charges and $14 million related to various transformation initiative costs, primarily consisting of changes to our business technology strategy. Fiscal 2023 includes $4 million related to restructuring and severance charges and $8 million related to various transformation initiative costs, primarily consisting of changes to our business technology strategy.
|
||||
(4)
|
Fiscal 2024 includes $28 million of intangible amortization expense and $3 million in acquisition and due diligence costs. Fiscal 2023 includes $26 million of intangible amortization expense and $4 million in acquisition and due diligence costs.
|
||||
(5)
|
Fiscal 2023 represents the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020. | ||||
(6)
|
The tax impact of adjustments for Certain Items are calculated by multiplying the pretax impact of each Certain Item by the statutory rates in effect for each jurisdiction where the Certain Item was incurred.
|
||||
(7)
|
Individual components of diluted earnings per share may not equal the total presented when added due to rounding. Total diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding. | ||||
NM represents that the percentage change is not meaningful. |
13-Week Period Ended Sep. 30, 2023 | 13-Week Period Ended Oct. 1, 2022 | Change in Dollars | %/bps Change | ||||||||||||||||||||
U.S. FOODSERVICE OPERATIONS | |||||||||||||||||||||||
Operating expenses (GAAP) | $ | 1,743,804 | $ | 1,706,631 | $ | 37,173 | 2.2 | % | |||||||||||||||
Impact of restructuring and transformational project costs | (55) | 48 | (103) | NM | |||||||||||||||||||
Impact of acquisition-related costs
(1)
|
(12,548) | (12,585) | 37 | 0.3 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(2)
|
— | 2,592 | (2,592) | NM | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | $ | 1,731,201 | $ | 1,696,686 | $ | 34,515 | 2.0 | % | |||||||||||||||
Operating income (GAAP) | $ | 940,971 | $ | 905,712 | $ | 35,259 | 3.9 | % | |||||||||||||||
Impact of restructuring and transformational project costs | 55 | (48) | 103 | NM | |||||||||||||||||||
Impact of acquisition-related costs
(1)
|
12,548 | 12,585 | (37) | (0.3) | |||||||||||||||||||
Impact of bad debt reserve adjustments
(2)
|
— | (2,592) | 2,592 | NM | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | $ | 953,574 | $ | 915,657 | $ | 37,917 | 4.1 | % | |||||||||||||||
INTERNATIONAL FOODSERVICE OPERATIONS | |||||||||||||||||||||||
Sales (GAAP) | $ | 3,683,210 | $ | 3,283,735 | $ | 399,475 | 12.2 | % | |||||||||||||||
Impact of currency fluctuations
(3)
|
(105,503) | — | (105,503) | (3.2) | |||||||||||||||||||
Comparable sales using a constant currency basis (Non-GAAP) | $ | 3,577,707 | $ | 3,283,735 | $ | 293,972 | 9.0 | % | |||||||||||||||
Gross profit (GAAP) | $ | 732,039 | $ | 649,265 | $ | 82,774 | 12.7 | % | |||||||||||||||
Impact of currency fluctuations
(3)
|
(26,711) | — | (26,711) | (4.1) | |||||||||||||||||||
Comparable gross profit using a constant currency basis (Non-GAAP) | $ | 705,328 | $ | 649,265 | $ | 56,063 | 8.6 | % | |||||||||||||||
Gross margin (GAAP) | 19.88 | % | 19.77 | % | 11 bps | ||||||||||||||||||
Impact of currency fluctuations
(3)
|
(0.17) | — | -17 bps | ||||||||||||||||||||
Comparable gross margin using a constant currency basis (Non-GAAP) | 19.71 | % | 19.77 | % | -6 bps | ||||||||||||||||||
Operating expenses (GAAP) | $ | 638,556 | $ | 562,285 | $ | 76,271 | 13.6 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(4)
|
(5,803) | (3,907) | (1,896) | (48.5) | |||||||||||||||||||
Impact of acquisition-related costs
(5)
|
(16,897) | (16,014) | (883) | (5.5) | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | 615,856 | 542,364 | 73,492 | 13.6 | |||||||||||||||||||
Impact of currency fluctuations
(3)
|
(25,417) | — | (25,417) | (4.7) | |||||||||||||||||||
Comparable operating expenses adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 590,439 | $ | 542,364 | $ | 48,075 | 8.9 | % | |||||||||||||||
Operating income (GAAP) | $ | 93,483 | $ | 86,980 | $ | 6,503 | 7.5 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(4)
|
5,803 | 3,907 | 1,896 | 48.5 | |||||||||||||||||||
Impact of acquisition-related costs
(5)
|
16,897 | 16,014 | 883 | 5.5 | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | 116,183 | 106,901 | 9,282 | 8.7 | |||||||||||||||||||
Impact of currency fluctuations
(3)
|
(1,294) | — | (1,294) | (1.2) | |||||||||||||||||||
Comparable operating income adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 114,889 | $ | 106,901 | $ | 7,988 | 7.5 | % | |||||||||||||||
SYGMA | |||||||||||||||||||||||
Operating expenses (GAAP) | $ | 140,043 | $ | 148,197 | $ | (8,154) | (5.5) | % | |||||||||||||||
Operating income (GAAP) | 12,767 | 5,696 | 7,071 | NM | |||||||||||||||||||
OTHER | |||||||||||||||||||||||
Operating expenses (GAAP) | $ | 66,152 | $ | 69,300 | $ | (3,148) | (4.5) | % | |||||||||||||||
Operating income (GAAP) | 11,823 | 11,538 | 285 | 2.5 | |||||||||||||||||||
13-Week Period Ended Sep. 30, 2023 | 13-Week Period Ended Oct. 1, 2022 | Change in Dollars | %/bps Change | ||||||||||||||||||||
GLOBAL SUPPORT CENTER | |||||||||||||||||||||||
Gross profit (loss) (GAAP) | $ | 173 | $ | (7,484) | $ | 7,657 | NM | ||||||||||||||||
Impact of inventory valuation adjustment
(6)
|
— | (2,571) | 2,571 | NM | |||||||||||||||||||
Gross profit (loss) adjusted for Certain Items (Non-GAAP) | $ | 173 | $ | (10,055) | $ | 10,228 | NM | ||||||||||||||||
Operating expenses (GAAP) | $ | 255,635 | $ | 265,641 | $ | (10,006) | (3.8) | % | |||||||||||||||
Impact of restructuring and transformational project costs
(7)
|
(13,817) | (7,786) | (6,031) | (77.5) | |||||||||||||||||||
Impact of acquisition-related costs
(8)
|
(1,593) | (855) | (738) | (86.3) | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | $ | 240,225 | $ | 257,000 | $ | (16,775) | (6.5) | % | |||||||||||||||
Operating loss (GAAP) | $ | (255,462) | $ | (273,125) | $ | 17,663 | 6.5 | % | |||||||||||||||
Impact of inventory valuation adjustment
(6)
|
— | (2,571) | 2,571 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(7)
|
13,817 | 7,786 | 6,031 | 77.5 | |||||||||||||||||||
Impact of acquisition-related costs
(8)
|
1,593 | 855 | 738 | 86.3 | |||||||||||||||||||
Operating loss adjusted for Certain Items (Non-GAAP) | $ | (240,052) | $ | (267,055) | $ | 27,003 | 10.1 | % | |||||||||||||||
(1)
|
Fiscal 2024 and fiscal 2023 include intangible amortization expense and acquisition costs.
|
||||
(2)
|
Fiscal 2023 represents the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020.
|
||||
(3)
|
Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on current year results. | ||||
(4)
|
Includes restructuring costs primarily in Europe. | ||||
(5)
|
Represents intangible amortization expense.
|
||||
(6)
|
Fiscal 2023 represents an adjustment to a product return allowance, related to COVID-related personal protection equipment inventory.
|
||||
(7)
|
Includes various transformation initiative costs, primarily consisting of changes to our business technology strategy. | ||||
(8)
|
Represents due diligence costs. | ||||
NM represents that the percentage change is not meaningful. |
13-Week Period Ended Sep. 30, 2023 | 13-Week Period Ended Oct. 1, 2022 | Change in Dollars | % Change | ||||||||||||||||||||
Net earnings (GAAP) | $ | 503,392 | $ | 465,568 | $ | 37,824 | 8.1 | % | |||||||||||||||
Interest (GAAP) | 134,334 | 124,150 | 10,184 | 8.2 | |||||||||||||||||||
Income taxes (GAAP) | 159,216 | 129,334 | 29,882 | 23.1 | |||||||||||||||||||
Depreciation and amortization (GAAP) | 206,007 | 188,924 | 17,083 | 9.0 | |||||||||||||||||||
EBITDA (Non-GAAP) | $ | 1,002,949 | $ | 907,976 | $ | 94,973 | 10.5 | % | |||||||||||||||
Certain Item adjustments: | |||||||||||||||||||||||
Impact of inventory valuation adjustment
(1)
|
$ | — | $ | (2,571) | $ | 2,571 | NM | ||||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
18,833 | 10,509 | 8,324 | 79.2 | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
2,629 | 3,546 | (917) | (25.9) | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
— | (2,592) | 2,592 | NM | |||||||||||||||||||
EBITDA adjusted for Certain Items (Non-GAAP)
(5)
|
$ | 1,024,411 | $ | 916,868 | $ | 107,543 | 11.7 | % |
(1)
|
Fiscal 2023 represents an adjustment to a product return allowance, related to COVID-related personal protection equipment inventory. | ||||
(2)
|
Fiscal 2024 and fiscal 2023 include charges related to restructuring and severance, as well as various transformation initiative costs, primarily consisting of changes to our business technology strategy, excluding charges related to accelerated depreciation.
|
||||
(3)
|
Fiscal 2024 and fiscal 2023 include acquisition and due diligence costs. | ||||
(4)
|
Fiscal 2023 represents the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020. | ||||
(5)
|
In arriving at adjusted EBITDA, Sysco does not adjust out interest income of $12 million and $3 million or non-cash stock compensation expense of $24 million and $27 million in fiscal 2024 and fiscal 2023, respectively.
|
||||
NM represents that the percentage change is not meaningful. |
13-Week Period Ended Sep. 30, 2023 | 13-Week Period Ended Oct. 1, 2022 | ||||||||||
Source of cash (use of cash) | (In thousands) | ||||||||||
Net cash provided by operating activities (GAAP) | $ | 87,152 | $ | 158,606 | |||||||
Additions to plant and equipment | (171,364) | (167,260) | |||||||||
Proceeds from sales of plant and equipment | 11,012 | 22,448 | |||||||||
Free Cash Flow (Non-GAAP)
(1)
|
$ | (73,200) | $ | 13,794 | |||||||
Acquisition of businesses, net of cash acquired | $ | (219,264) | $ | (32,651) | |||||||
Debt borrowings (repayments), net | 407,229 | 137,959 | |||||||||
Stock repurchases | (99,974) | (267,727) | |||||||||
Dividends paid | (252,880) | (249,294) | |||||||||
(1)
|
Free cash flow should not be used as a substitute for the most comparable GAAP measure in assessing the company’s liquidity for the periods presented. An analysis of any non-GAAP financial measure should be used in conjunction with results presented in accordance with GAAP. See Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Key Performance Indicators” contained in our fiscal 2023 Form 10-K for discussions regarding this non-GAAP performance metric.
|
Combined Parent and Guarantor Subsidiaries Summarized Balance Sheet | Sep. 30, 2023 | Jul. 1, 2023 | ||||||||||||
(In thousands) | ||||||||||||||
ASSETS | ||||||||||||||
Receivables due from non-obligor subsidiaries | $ | 272,246 | $ | 321,476 | ||||||||||
Current assets | 5,723,242 | 5,149,509 | ||||||||||||
Total current assets | $ | 5,995,488 | $ | 5,470,985 | ||||||||||
Notes receivable from non-obligor subsidiaries | $ | 109,020 | $ | 108,380 | ||||||||||
Other noncurrent assets | 4,356,920 | 4,254,145 | ||||||||||||
Total noncurrent assets | $ | 4,465,940 | $ | 4,362,525 | ||||||||||
LIABILITIES | ||||||||||||||
Payables due to non-obligor subsidiaries | $ | 139,794 | $ | 71,175 | ||||||||||
Other current liabilities | 2,210,744 | 2,305,435 | ||||||||||||
Total current liabilities | $ | 2,350,538 | $ | 2,376,610 | ||||||||||
Notes payable to non-obligor subsidiaries | $ | 239,892 | $ | 240,874 | ||||||||||
Long-term debt | 10,148,155 | 9,793,541 | ||||||||||||
Other noncurrent liabilities | 1,213,561 | 1,121,884 | ||||||||||||
Total noncurrent liabilities | $ | 11,601,608 | $ | 11,156,299 |
Combined Parent and Guarantor Subsidiaries Summarized Results of Operations | 13-Week Period Ended Sep. 30, 2023 | |||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||
Sales | $ | 12,311,637 | ||||||||||||||||||||||||
Gross profit | 2,262,288 | |||||||||||||||||||||||||
Operating income | 663,645 | |||||||||||||||||||||||||
Interest expense from non-obligor subsidiaries | 2,698 | |||||||||||||||||||||||||
Net earnings | 387,862 |
ISSUER PURCHASES OF EQUITY SECURITIES | |||||||||||||||||||||||
Period |
Total Number of Shares Purchased
(1)
|
Average Price Paid per Share |
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
(2)
|
Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs | |||||||||||||||||||
Month #1 | |||||||||||||||||||||||
July 2 - July 29 | 292,233 | $ | 74.37 | 292,233 | — | ||||||||||||||||||
Month #2 | |||||||||||||||||||||||
July 30 - August 26 | 593,685 | 73.18 | 593,685 | — | |||||||||||||||||||
Month #3 | |||||||||||||||||||||||
August 27 - September 30 | 497,029 | 69.96 | 497,029 | — | |||||||||||||||||||
Totals | 1,382,947 | $ | 72.28 | 1,382,947 | — |
(1)
|
The total number of shares purchased includes no shares tendered by individuals in connection with stock option exercises in Month #1, Month #2 or Month #3.
|
||||
(2)
|
See the discussion in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources – Equity Transactions” for additional information regarding Sysco’s share repurchase program.
|
Name | Title | Action | Date | Trading Arrangement |
Number of Securities Converted
|
Expiration Date
(4)
|
|||||||||||||||||
Rule 10b5-1
(1)
|
Non-Rule 10b5-1
(2)
|
||||||||||||||||||||||
|
|
Adopt |
|
X |
|
March 1, 2024 | |||||||||||||||||
|
|
Adopt |
|
X |
|
December 31, 2024 | |||||||||||||||||
|
Corporate Affairs and Chief Administrative Officer |
Adopt |
|
X |
1,000 shares to be acquired and held upon the exercise of vested stock options
|
December 29, 2023 | |||||||||||||||||
|
|
Adopt |
|
X |
|
March 7, 2024 |
(1)
|
Intended to satisfy the affirmative defense conditions of SEC Rule 10b5-1(c). | ||||
(2)
|
Non-Rule Rule 10b5-1 trading arrangement as defined in Item 408 of Regulation S-K. | ||||
(3)
|
The shares reported for Mr. Bertrand include 3,444 shares directly held by Mr. Bertrand’s children and covered under three separate trading plans with identical adoption and expiration dates. | ||||
(4)
|
Each Plan terminates on the earlier of: (i) the expiration date listed in the table above; (ii) the first date on which all trades set forth in the Plan have been executed; or (iii) such date the Plan is otherwise terminated according to its terms. |
3.1 | — | |||||||
3.2 | — | |||||||
3.3 | — | |||||||
3.4 | — | |||||||
10.1†# | — | |||||||
10.2†# | — | |||||||
10.3†# | — | |||||||
10.4†# | — | |||||||
10.5†# | — | |||||||
10.6† | — | |||||||
10.7†# | — | |||||||
10.8†# | — | |||||||
22.1 | — | |||||||
31.1# | — | |||||||
31.2# | — | |||||||
32.1# | — | |||||||
32.2# | — | |||||||
101.SCH# | — | Inline XBRL Taxonomy Extension Schema Document | ||||||
101.CAL# | — | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||||
101.DEF# | — | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||||
101.LAB# | — | Inline XBRL Taxonomy Extension Labels Linkbase Document | ||||||
101.PRE# | — | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||||
104 | — | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
Sysco Corporation | ||||||||
(Registrant) | ||||||||
Date: October 31, 2023 | By: | /s/ KEVIN P. HOURICAN | ||||||
Kevin P. Hourican | ||||||||
President and Chief Executive Officer | ||||||||
Date: October 31, 2023 | By: | /s/ KENNY K. CHEUNG | ||||||
Kenny K. Cheung | ||||||||
Executive Vice President and | ||||||||
Chief Financial Officer | ||||||||
Date: October 31, 2023 | By: | /s/ JENNIFER L. JOHNSON | ||||||
Jennifer L. Johnson | ||||||||
Senior Vice President and | ||||||||
Chief Accounting Officer |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Suppliers
Supplier name | Ticker |
---|---|
Berry Global Group, Inc. | BERY |
Silgan Holdings Inc. | SLGN |
Ball Corporation | BLL |
AptarGroup, Inc. | ATR |
Heartland Express, Inc. | HTLD |
Ingredion Incorporated | INGR |
Bemis Company, Inc. | BMS |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|